Nano Pharmaceuticals

Vista Pharmaceuticals Ltd.

VISTAPH

Market Cap
₹44 Cr.
P/E
0.00

Vista Pharmaceuticals Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
44.00 Cr
PE
PE
-
Prom Holding
Prom Holding
21.19 %
ROE (%)
ROE (%)
-
ROCE (%)
ROCE (%)
-9.93
Div Yield (%)
Div Yield (%)
-
Sales
Sales
5.40 Cr
OPM (%)
OPM (%)
-270 %
Debt to Equity
Debt to Equity
0.16
Institutions
Institutions
0.02 %
Individual < 2 lac
Individual < 2 lac
14.73 %
No. of Shareholders
No. of Shareholders
14,154
View more
Edit Ratio's

About

Vista Pharmaceuticals Limited, founded in 1992, manufactures and sells a wide range of pharmac… Read more
Low
6
52W Range
High
12
  • Vista Pharmaceutical
  • Mangalam Drugs&Org.
  • Rajnish Wellness

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

Edit rows

Forensics

7 Yes

Positive for this company

1 Neutral

Neutral for this company

6 No

Negative for this company

2 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Peer Comparison

FAQs on Vista Pharmaceuticals Ltd. Business

Vista Pharmaceuticals Limited manufactures and sells pharmaceutical, medical, and veterinary preparations, including a range of generic drug products. Founded in 1992 with a vision to expand globally.

Vista Pharmaceutical major competitors are Mangalam Drugs&Org., Rajnish Wellness, ANG Lifesciences, Shanmuga Hospital, Vivimed Labs, Goldline Pharma., Shelter Pharma.
Market Cap of Vista Pharmaceutical is ₹45 Crs.
While the median market cap of its peers are ₹45 Crs.

Vista Pharmaceutical seems to be less financially stable compared to its competitors.
Altman Z score of Vista Pharmaceutical is 1.2 and is ranked 5 out of its 8 competitors.

View FAQ's On Shareprice

Company Filing

2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary

Discussions & Analysis

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material